R&D Systems™ Recombinant Human CD8 alpha/beta Heterodimer Protein

Catalog No.	Quantity
93-58C-D050	50 μg

Catalog No. 93-58C-D050 Supplier R&D Systems™ Supplier No. 9358CD050

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human CD8 alpha/beta Heterodimer Protein is derived from HEK293. The Recombinant Human CD8 alpha/beta Heterodimer Protein has been validated for the following applications: Bioactivity.

Order Info

Ships at ambient temperature.

Specifications

• Accession Number: P01732 (CD8 alpha), P10966 (CD8 beta)
• Formulation: Lyophilized from a 0.2μm filtered solution in PBS
• Gene ID (Entrez): 925
• Molecular Weight (g/mol): 26 kDa
• Quantity: 50 μg
• Source: Human embryonic kidney cell,HEK293-derived human CD8 protein, (N-terminus) Human CD8 alpha (Ser22-Asp182) Accession &Num; P01732 Acidic Tail HHHHHH Human CD8 beta (Asn19-Pro170) Accession &Num; P10966 Basic Tail FLAG (DYKDDDDK) (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Structural Form: Disulfide-linked heterodimer
• Endotoxin Concentration: <0.10 EU per 1μg of the protein by the LAL method
• Biological Activity: 0.8 to 4μg/mL
• Product Type: Recombinant protein
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining

For Research Use Only.